Practice Areas

  • Individual & Corporate Criminal Defense
  • Corporate Ethics & Compliance Programs
  • Internal Investigations

From The Blog

Episode 150: Review of Novartis False Claims Act and Anti-Kickback Settlements for $729 Million

Novartis is the new poster-child of corporate misconduct.  In the space of two weeks, Novartis settled domestic

read more

Alexion FCPA Violations: Lessons Learned (Part II of II)

The Alexion Pharmaceutical SEC FCPA enforcement action represents another in the long line of enforcement actions

read more